In a controversial operation, the US military struck two boats allegedly involved in drug smuggling, resulting in multiple casualties. Legal experts are questioning the legality of these actions amidst the ongoing 'war on drugs' campaign.
In a bold declaration, Trump claims he has drastically reduced drug trafficking and illegal border crossings, but quickly shifts focus to Venezuelan President Maduro. What does this mean for US foreign policy?
In a groundbreaking move, President Trump has forged agreements with major pharmaceutical companies to significantly lower drug prices for Americans, ensuring access to affordable medications for chronic conditions.
New revelations surrounding a U.S. military strike on a drug-carrying vessel raise alarming questions about legality and ethics, as survivors attempted to salvage drugs before a second attack.
In a recent Cabinet meeting, President Trump made numerous false claims about inflation, grocery prices, and foreign aid. This article fact-checks his 13 inaccurate assertions and clarifies the truth behind them.
Exciting developments in Alzheimer's research reveal that two existing drugs may reverse brain damage in mice, offering hope for future human trials as awareness grows ahead of the Walk to End Alzheimer’s.
Despite losing a $10 billion bid for Metsera to Pfizer, Novo Nordisk's CEO Mike Doustdar remains determined to pursue new opportunities in the obesity and diabetes sectors. The company aims to reclaim its position in the booming weight-loss market.
Eli Lilly & Co. and Novo Nordisk A/S have struck a deal with the Trump administration to lower prices for their popular weight-loss drugs, Zepbound and Wegovy, while gaining tariff relief and expanding Medicare access. This agreement aims to increase availability for older Americans.
In a groundbreaking move, the Trump administration has announced new agreements with Novo Nordisk and Eli Lilly to significantly reduce the cost of GLP-1 medications for American patients, including those on Medicare. With prices set to drop dramatically, millions will soon benefit from affordable access to essential treatments.
In a groundbreaking move, President Trump has negotiated significant price reductions for popular weight loss medications, bringing costs down to as low as $50 per month for eligible patients. Find out how these changes will affect access to essential treatments!